Patents by Inventor Melvyn Baez

Melvyn Baez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Rhesus monkey neuropeptide Y Y2 receptor
    Patent number: 6355478
    Abstract: This invention describes a novel rhesus monkey receptor having affinity for neuropeptide Y, pancreatic polypeptide, and peptide YY. This invention also encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds.
    Type: Grant
    Filed: June 16, 1997
    Date of Patent: March 12, 2002
    Assignee: Eli Lilly and Company
    Inventors: Melvyn Baez, Peiyi Yang
  • Rhesus neuropeptide Y5 receptor
    Patent number: 6242251
    Abstract: This invention describes a novel rhesus receptor having affinity for neuropeptide Y, pancreatic polypeptide, and peptide YY. This invention also encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds.
    Type: Grant
    Filed: March 18, 1998
    Date of Patent: June 5, 2001
    Assignee: Eli Lilly and Company
    Inventors: Melvyn Baez, Peiyi Yang
  • Rhesus neuropeptide Y1 receptor
    Patent number: 6087154
    Abstract: This invention describes a rhesus receptor, designated the rhesus Y1 receptor, having affinity for neuropeptide Y, pancreatic polypeptide, and peptide YY. This invention also encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds.
    Type: Grant
    Filed: March 20, 1998
    Date of Patent: July 11, 2000
    Assignee: Eli Lilly and Company
    Inventors: Melvyn Baez, Carolyn Ann George
  • Serotonin receptor protein and related nucleic acid compounds
    Patent number: 5698444
    Abstract: This invention describes a novel human serotonin receptor, designated 5-HT.sub.2B. This invention also encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds.
    Type: Grant
    Filed: December 23, 1993
    Date of Patent: December 16, 1997
    Assignee: Eli Lilly and Company
    Inventors: Melvyn Baez, Jonathan D. Kursar